|

Suvorexant (dual orexin receptor antagonist) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Marianne Goodman1

Indications

  • Suicide Risk1
  • Major Depressive Disorder (MDD)1
  • Depression1

The Bronx, New York1 trial

Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial

James J. Peters Veterans Affairs Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.